Albert W Brzeczko - Net Worth and Insider Trading
Albert W Brzeczko Net Worth
The estimated net worth of Albert W Brzeczko is at least $6,320 dollars as of 2024-07-17. Albert W Brzeczko is the VP Technical Affairs - APT of Acura Pharmaceuticals Inc and owns about 316,000 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $6,320. Details can be seen in Albert W Brzeczko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Albert W Brzeczko has not made any transactions after 2017-12-14 and currently still holds the listed stock(s).
Transaction Summary of Albert W Brzeczko
Albert W Brzeczko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Albert W Brzeczko owns 1 companies in total, including Acura Pharmaceuticals Inc (ACUR) .
Click here to see the complete history of Albert W Brzeczko’s form 4 insider trades.
Insider Ownership Summary of Albert W Brzeczko
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACUR | Acura Pharmaceuticals Inc | 2020-01-02 | VP Pharmaceutical Sciences APT |
Albert W Brzeczko Latest Holdings Summary
Albert W Brzeczko currently owns a total of 1 stock. Albert W Brzeczko owns 316,000 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $6,320.
Latest Holdings of Albert W Brzeczko
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACUR | Acura Pharmaceuticals Inc | 2017-12-14 | 316,000 | 0.02 | 6,320 |
Holding Weightings of Albert W Brzeczko
Albert W Brzeczko Form 4 Trading Tracker
According to the SEC Form 4 filings, Albert W Brzeczko has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the acquisition of 300,000 shares on December 14, 2017, which cost Albert W Brzeczko around $30,000.
Insider Trading History of Albert W Brzeczko
- 1
Albert W Brzeczko Trading Performance
GuruFocus tracks the stock performance after each of Albert W Brzeczko's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Albert W Brzeczko is 29.57%. GuruFocus also compares Albert W Brzeczko's trading performance to market benchmark return within the same time period. The performance of stocks bought by Albert W Brzeczko within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Albert W Brzeczko's insider trading performs compared to the benchmark.
Performance of Albert W Brzeczko
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 28.35 | | | | | |
| Relative Return to S&P 500(%) | 24.32 | | | | | |
Albert W Brzeczko Ownership Network
Albert W Brzeczko Owned Company Details
What does Acura Pharmaceuticals Inc do?
Who are the key executives at Acura Pharmaceuticals Inc?
Albert W Brzeczko is the VP Pharmaceutical Sciences APT of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Corporate Development James F Emigh , VP & Treasurer & Controller Robert A Seiser , and President & CEO Robert B Jones .
Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acura Pharmaceuticals Inc Insider Transactions
Albert W Brzeczko Mailing Address
Above is the net worth, insider trading, and ownership report for Albert W Brzeczko. You might contact Albert W Brzeczko via mailing address: C/o Acura Pharmaceuticals, Inc. 660 N. North Court Palatine Il 60067.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
